Anticancer Agent “TASFYGO Tablets 35mg” (Tasurgratinib Succinate) Launches in Japan for Biliary Tract Cancer with FGFR2 Gene Fusion or Rearrangements

TOKYO, Nov 20, 2024 - (JCN Newswire via SeaPRwire.com) - Eisai Co., Ltd. announced today that it has launched fibroblast growth factor receptor (FGFR) selective tyrosine kinase inhibitor “TASFYGO® Tablets 35mg” (generic name: tasurgratinib succinate) in Japan for the treatment of patients with unresectable biliary tract cancer with FGFR2 gene…

LQR House Inc. Board of Directors Approves Purchase of Up to $1M Bitcoin as Treasury Reserve Asset and Retention of Up to $10M Crypto Payments on CWSpirits.com

MIAMI, FL, Nov 19, 2024 - (ACN Newswire via SeaPRwire.com) - LQR House Inc. (the "Company" or "LQR House") (NASDAQ:LQR), a niche e-commerce platform specializing in the spirits and beverage industry, today announced that its Board of Directors has approved the purchase of up to $1 million in Bitcoin as part…

GMG Reaches Market Commercialisation Milestone on Energy Savings Coating THERMAL-XR(R)

Brisbane, Queensland, Australia--(ACN Newswire via SeaPRwire.com - November 19, 2024) - Graphene Manufacturing Group Ltd. (TSXV: GMG) (OTCQX: GMGMF) ("GMG" or the "Company") is pleased to provide a business update on the commercialisation progress of THERMAL-XR® Powered by GMG Graphene.SINGAPORE GREEN BUILDING COUNCIL PRODUCT APPROVALThe Singapore Green Building Council has…

Kingsoft Announces 2024 Third Quarter Results

FINANCIAL HIGHLIGHTSRMB’000 (Unaudited)For the three months ended30 September 202430 September202330 June2024Revenue2,914,7852,059,6792,473,766- Office Software and Services1,206,8151,098,3251,187,730- Online Games and Others1,707,970961,3541,286,036Gross Profit2,454,4441,676,8542,042,035Operating Profit1,144,118376,073794,037Profit Attributable to Owners of the Parent413,44928,492393,353Basic Earnings per Share (RMB)0.310.020.29HONG KONG, Nov 19, 2024 - (ACN Newswire via SeaPRwire.com) - Kingsoft Corporation Limited (“Kingsoft” or the “Company”; Stock Code:…

NTT and Olympus Joint Demonstration Shows IOWN APN’s Low-latency Capability Can Be Used for Real-time Diagnosis and Treatment on a Remote Server to Realize World’s First Cloud Endoscopy System

News Highlights:By configuring the cloud endoscopy system with the latest IOWN APN1 (All Photonics Network; “APN”) technology, issues with latency were resolved, confirming that real-time diagnosis and treatment for patients through a remote server 150km away is feasible.Based on this result, NTT and Olympus will collaborate in studying the technical…